Novel polythiophene compounds useful as anti-tumor agents are described. Preferred compounds of the formula: ##STR1## wherein n is 0-2 and R.sub.2 and R.sub.3 are optionally substituted 2-thienyl or 3-thienyl have been found to exhibit selective cytotoxic activity against transformed human cells. Pharmaceutical compositions containing the described polythiophene compounds are expected to exhibit good chemotherapeutic activity against slow growing tumors based on tumor cell line assays. A method for treating patients having tumors utilizing the disclosed polythiophene compounds is also described.
本发明涉及一种用作抗肿瘤剂的新型聚
噻吩化合物。该化合物的首选式为:##STR1## 其中n为0-2,R.sub.2和R.sub.3为可选取代的2-
噻吩基或3-
噻吩基,已发现该化合物对转化人类细胞表现出选择性细胞毒性活性。预期含有上述聚
噻吩化合物的制药组合物将在基于肿瘤
细胞系检测的基础上对慢性生长的肿瘤表现出良好的
化学治疗活性。本发明还涉及一种利用上述聚
噻吩化合物治疗患有肿瘤的患者的方法。